Our recent study [11] and others [12, 13, 14, 15, 16] have found that TRIP13 is upregulated in colorectal cancers (CRCs; 55–80%), promotes cancer cell growth, promotes disease progression and indicates poor patient survival. This evidence concerns the gene TRIP13 and colorectal cancer.